Janux Therapeutics (JANX) PT Lowered to $89 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Jeffrey La Rosa lowered the price target on Janux Therapeutics (NASDAQ: JANX) to $89.00 (from $91.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
